This Week Last Year in Medtech: May 21-27

25 Most Attractive Medtech M&A Targets in 2022

These public medtech companies were identified as attractive for potential M&A based on products, growth, and margins. List does not account for valuations.

LabCorp Is Focusing on Skin Cancer with New Test

The Burlington, NC-based company’s melanoma test determines the level of expression of the lymphocyte-activation gene 3 (LAG-3).

What Would a Dexcom-Insulet Merger Look Like?

Dexcom is rumored to be in acquisition talks with Insulet. Such a deal would have a major impact on the competitive landscape for diabetes tech.

Apple Watch ECG Readings Plus AI Detect Weak Hearts

Mayo Clinic researchers developed the AI algorithm to interpret single-lead ECG tracings from an Apple Watch to more effectively identify patients who are living with a weak heart pump.

LumiraDx Scores CE Mark for Fast POC COVID-19 Test

The London-based company said the assay detects the presence of antigens in five minutes.

Illumina Obtains CDx Pan-Cancer Indication for TruSight Test

The test, which has CE mark, would be a companion diagnostic to Bayer’s Vitrakvi, a cancer treatment drug.

Stryker Launches EasyFuse Compression System

The Kalamazoo, MI-based company’s device is for high-demand foot and ankle applications.

Why Diversity in Medtech Matters

MedTech Color, a nonprofit organization formed in 2018, is making gains toward greater medtech diversity.

Medtronic to Spin Renal Business into New Company

Medtronic will co-own the new kidney device company with DaVita, each with equal equity stakes.